Philip J. Rosenthal is a Professor in the Department of Medicine at the University of California, San Francisco (UCSF) and Associate Chief for Academic Affairs and Research in the Division of HIV, Infectious Diseases, and Global Medicine at San Francisco General Hospital. At UCSF he is a member of the Biomedical Sciences Graduate Program and the Global Health Sciences Program. He has directed an NIH/Fogarty International Center training program entitled ‘Training in Malaria Research in Uganda’ since 2000. Dr. Rosenthal has served as the Editor-in-Chief of the American Journal of Tropical Medicine and Hygiene since January, 2014, and he is on the editorial boards of four other medical journals. He has served on numerous review groups and advisory bodies for the NIH, WHO, Medicines for Malaria Venture, and other organisations. Dr Rosenthal’s research, funded principally by the NIH, focuses on the treatment of malaria, including studies of antimalarial treatment and chemopreventive efficacy, translational studies of drug resistance, evaluation of antimalarial pharmacokinetics and pharmacodynamics, characterisation of mechanisms of action of novel antimalarial agents, and antimalarial drug discovery. Primary research sites are in Uganda and at UCSF, and collaborations are in place with groups in a number of other countries.

Philip Rosenthal has broad interests in the Infectious Diseases and Cell Biology.. His research thus far has focused on Microbiology, Tumor and Cell Biology.